Long-term outcome with the use of OKT3 induction therapy in heart transplan patients: A single-center experience

Transplantation Proceedings

Volumn 30, Issue 4, 1998, Pages 1107-1109

  Adamson, R ^a,b   Obispo, E ^a   Dychter, S ^a   Dembitsky, W ^a   Moreno Cabral, R ^a   Jaski, B ^a   Gordon, J ^a   Hoagland, P ^a   Moore, K ^a   King, J ^a   Andrews, J ^a   Rich, M ^a   Daily, P O ^a  

^a Sharp Mem Heart Transplant Center   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE SODIUM SUCCINATE; OKT 3; PREDNISONE;

ADULT; ALLOGRAFT; CANCER; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT REJECTION; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AZATHIOPRINE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MUROMONAB-CD3; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; STEROIDS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 13144250161     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(98)00171-7     Document Type: Conference Paper

References (6)

1. Costanzo-Nordin MR, O'Sullivan EJ, Hubbell EA, et al: J Heart Transplant 8:288, 1989
2. Gay WA, O'Connell JG, Burton NA, et al: Ann Surg 208:287, 1988
3. Pulpon LA, Dominguez P, Chafer M, et al: Transplant Proc 22:2319, 1990
4. Laske A, Gallino A, Schneider J, et al: J Heart Lung Transplant 11:357, 1992
5. Ladowski JS, Dillon T, Schatzlein HH, et al: J Cardiovasc Surg 34:135, 1993
6. Carrier M, Jenicek M, Pelletier LC: Transplant Proc 24:2586, 1992